Varying high levels of faecal carriage of extended-spectrum beta-lactamase producing enterobacteriaceae in rural villages in Shandong, China: Implications for global health

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Sun, Qiang ^a   Tärnberg, Maria ^b   Zhao, Lingbo ^a   Stalsby Lundborg, Cecilia ^c   Song, Yanyan ^d   Grape, Malin ^e   Nilsson, Maud ^b   Tomson, Göran ^c   Nilsson, Lennart E ^b  

^a BEIJING HOSPITAL   (China)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SHANDONG UNIVERSITY   (China)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; COLISTIN; BETA LACTAMASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; ENTEROBACTERIACEAE INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FECES ANALYSIS; HEALTH CARE SYSTEM; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NONHUMAN; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; RURAL AREA; SOCIOECONOMICS; AGE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; FECES; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; RURAL POPULATION;

ENTEROBACTERIACEAE;

AGE FACTORS; BETA-LACTAMASES; CHINA; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; HUMANS; PREVALENCE; RISK FACTORS; RURAL POPULATION; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84912098501     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113121     Document Type: Article

References (28)

1. Cars O, Högberg LD, Murray M, Nordberg O, Sivaraman S, et al. (2008) Meeting the challenge of antibiotic resistance. BMJ 337: 1438-1441.
2. WHO (2012) The evolving threat of antimicrobial resistance: options for action. Geneva: World Health Organisation.
3. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, et al. (2013) Antibiotic resistance-the need for global solutions. Lancet Infectious Dis 13: 1057-1098.
4. Yezli S, Li H (2012) Antibiotic resistance amongst healthcare-associated pathogens in China. Int J Antimicrob Agents 40: 389-397.
5. Heddini A, Cars O, Qiang S, Tomson G (2009) Antibiotic resistance in China-a major future challenge. Lancet 373: 30.
6. Doumith M, Dhanji H, Ellington MJ, Hawkey P, Woodford N (2012) Characterization of plasmids encoding extended-spectrum beta-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK. J Antimicrob Chemother 67: 878-885.
7. Luvsansharav UO, Hirai I, Nakata A, Imura K, Yamauchi K, et al. (2012) Prevalence of and risk factors associated with faecal carriage of CTX-M beta-lactamase-producing Enterobacteriaceae in rural Thai communities. J Antimicrob Chemother 67: 1769-1774.
8. Abdul Rahman EM, EI-Sherif RH (2011) High rates of intestinal colonization with extended spectrum beta-lactamase producing Enteroibacteriaceae among healthy individuals. J Investig Med 59: 1284-1286.
9. Li B, Sun JY, Liu QZ, Han LZ, Huang XH, et al. (2011) High prevalence of CTX-M beta-lactamases in faecal Escherichia coli strains from healthy humans in Fuzhou, China. Scand J Infect Dis 43: 170-174.
10. Strömdahl H, Tham J, Melander E, Walder M, Edquist PJ, et al. (2011) Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis 30: 1159-1162.
11. Tian GB, Wang HN, Zhang AY, Zhang Y, Fan WQ, et al. (2012) Detection of clinically important beta-lactamases in commensal Eschericha coli of human and swine origin in western China. J Med Microbiol 61: 233-8.
12. Hu YY, Cai JC, Zhou HW, Chi D, Zhang XF, et al. (2013) Molecular typing of CTX-M-producing Escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients. Appl Environ Microbiol 79: 5988-5996.
13. Tian SF, Chen BY, Chu YZ, Wang S (2008) Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China. Can J Microbiol 54: 781-785.
14. Lo WU, Ho PL, Chow KH, Lai EL, Yeung F, et al. (2010) Fecal carriage of CTXM type extended-spectrum beta-lactamase producing organisms by children and their household contacts. J Infect 60: 286-292.
15. Yip WC, Hsiao WC, Chen W, Hu S, Ma J, et al. (2012) Early appraisal of China's huge and complex health-care reforms. Lancet 379: 833-842.
16. Health and Family Planning Commission of Shandong Province (2013) Shandong Health Statistic Yearbook. China Tushu Publishing Limited.
17. Dong L, Yan H, Wang D (2011) Drug prescribing indicators in village health clinics across 10 provinces of Western China. Fam Pract 28: 63-67.
18. Colodner R, Rock W, Chazan B, Keller N, Guy N, et al. (2004) Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23: 163-167.
19. Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, et al. (2006) Risk factors for communityonset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother 57: 780-783.
20. Rodríguez-Baño J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, et al. (2004) Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase- producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42: 1089-1094.
21. Rodríguez-Baño J, Lopez-Cerero L, Navarro MD, Martínez-Martínez L, Muniain MA, et al. (2008) Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 62: 1142-1149.
22. Lim SK, Kim TS, Lee HS, Nam HM, Joo YS, et al. (2006) Persistence of vanA-type Enterococcus faecium in Korean livestock after ban on avoparcin. Microb Drug Resist. Summer; 12(2): 136-9.
23. Ghidán A, Dobay O, Kaszanyitzky EJ, Samu P, Amyes SG, et al. (2008) Vancomycin resistant enterococci (VRE) still persist in slaughtered poultry in Hungary 8 years after the ban on avoparcin. Acta Microbiol Immunol Hung. Dec; 55(4): 409-17.
24. Sundqvist M, Geli P, Andersson DI, Sjölund-Karlsson M, Runehagen A, et al. (2010) Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother. Feb; 65(2): 350-60.
25. Enne VI, Livermore DM, Stephens P, Hall LM (2001) Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet. Apr 28; 357(9265): 1325-8. Erratum in: Lancet 2001 Jun 9; 357(9271): 1890.
26. Bean DC, Livermore DM, Papa I, Hall LM (2005) Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. J Antimicrob Chemother. Nov; 56(5): 962-4.
27. Coast J, Smith RD (2003) Solving the problem of antimicrobial resistance: is a global approach necessary? Drug Discov Today 8: 1-2.
28. Nordberg P, Sta˚lsby Lundborg C, Tomson G (2005) Consumers and providers. Could they make better use of antibiotics? Int J Risk Saf Med 17: 117-125.